245 related articles for article (PubMed ID: 17908796)
21. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
Zhang W; Bergamaschi D; Jin B; Lu X
Blood; 2005 May; 105(9):3691-8. PubMed ID: 15665120
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4.
Kardinal C; Dangers M; Kardinal A; Koch A; Brandt DT; Tamura T; Welte K
Blood; 2006 Feb; 107(3):1133-40. PubMed ID: 16195327
[TBL] [Abstract][Full Text] [Related]
23. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima H; Hunter T
Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
[TBL] [Abstract][Full Text] [Related]
24. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
[TBL] [Abstract][Full Text] [Related]
25. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
26. Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2.
Pack LR; Daigh LH; Chung M; Meyer T
Nat Commun; 2021 Jun; 12(1):3356. PubMed ID: 34099663
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.
Susaki E; Nakayama K; Nakayama KI
Mol Cell Biol; 2007 Jul; 27(13):4626-40. PubMed ID: 17452458
[TBL] [Abstract][Full Text] [Related]
29. HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.
Le XF; Pruefer F; Bast RC
Cell Cycle; 2005 Jan; 4(1):87-95. PubMed ID: 15611642
[TBL] [Abstract][Full Text] [Related]
30. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
[TBL] [Abstract][Full Text] [Related]
31. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
32. Inability to phosphorylate Y88 of p27
Jäkel H; Taschler M; Jung K; Weinl C; Pegka F; Kullmann MK; Podmirseg SR; Dutta S; Moser M; Hengst L
Leukemia; 2022 Jul; 36(7):1916-1925. PubMed ID: 35597806
[TBL] [Abstract][Full Text] [Related]
33. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
34. New functional activities for the p21 family of CDK inhibitors.
LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
[TBL] [Abstract][Full Text] [Related]
35. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.
Reynisdóttir I; Massagué J
Genes Dev; 1997 Feb; 11(4):492-503. PubMed ID: 9042862
[TBL] [Abstract][Full Text] [Related]
36. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
[TBL] [Abstract][Full Text] [Related]
37. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
Paternot S; Colleoni B; Bisteau X; Roger PP
Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
[TBL] [Abstract][Full Text] [Related]
38. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition.
Guiley KZ; Stevenson JW; Lou K; Barkovich KJ; Kumarasamy V; Wijeratne TU; Bunch KL; Tripathi S; Knudsen ES; Witkiewicz AK; Shokat KM; Rubin SM
Science; 2019 Dec; 366(6471):. PubMed ID: 31831640
[TBL] [Abstract][Full Text] [Related]
39. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.
Orlando S; Gallastegui E; Besson A; Abril G; Aligué R; Pujol MJ; Bachs O
Nucleic Acids Res; 2015 Aug; 43(14):6860-73. PubMed ID: 26071952
[TBL] [Abstract][Full Text] [Related]
40. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
Polyak K; Lee MH; Erdjument-Bromage H; Koff A; Roberts JM; Tempst P; Massagué J
Cell; 1994 Jul; 78(1):59-66. PubMed ID: 8033212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
